The Global Sepsis Diagnostics Market was worth USD 793.7 million in 2016 and estimated to be growing at a CAGR of 8.51%, to reach USD 1,283.3 million by 2022
Sepsis can be defined as the body’s reaction to the fungal, bacterial, viral, or parasitic infection, which may further lead to systemic inflammatory reaction and organ dysfunction or organ failure. Sepsis is one of the most common causes of death in hospitalized patients.
According to data revealed by the Centers for Disease Control and Prevention, sepsis affects around 800,000 people in the U.S. each year and it is the ninth leading cause of disease-related deaths in North America.
Death can be as a result of hypotension, organ failure, high heart rate, and extreme body temperatures or due to a combination of these. It is more common in the elderly and infants.
Request free sample report at www.marketdataforecast.com/market-…43/request-sample
The growth of Sepsis Diagnostics market is attributed to factors like rising prevalence of different antibiotic resistant bacterial strains, increasing geriatric population, growing number of surgical procedures, high incidence rates of hospital acquired infections and increasing number of product approvals. However factors like lack of standard protocols, lack of awareness and dearth or skilled staff are likely to hamper the growth of market.
The Global market for Sepsis Diagnostics is segmented based on Pathogen, Product, Technology, Method and Usability. Based on Pathogen – Bacterial and Fungal.
Based on Product - Instruments, Blood Culture Media, Assay Kits and Reagents. Based on Technology - Molecular Diagnostics, Microbiology, Immunoassay and Flow Cytometry.
Based on Method – Conventional and Automated. Based on Usability - Laboratory and Point-of-care testing.
Based on Geographical analysis the market is separated into regions of North America, Asia-Pacific, Europe, Latin America and Middle East and Africa. North America is leading the market while Europe is at second place.
Growing focus of stakeholders on research projects, drug discovery and diagnosis has helped North America dominate the market. Asia Pacific is expected to grow the fastest owing to number of factors such as increasing number of surgical procedures, growing number of clinical studies, developing healthcare infrastructure, and rising focus of global players in this region.
Bacterial Sepsis Diagnostics have accounted for major share among the pathogen segment. Molecular Diagnostics is expected to grow the fastest among the technology segment.
Blood culture media is regarded as the standard treatment procedure and holds the major share among the products segment.
Some of the key players dominating this market include bioMérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!